Mai Iwaya1,2,3, Hiroyoshi Ota4, Tomoyuki Nakajima5, Takeshi Uehara5, Robert Riddell6,7, James Conner6,7. 1. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. mkatou@shinshu-u.ac.jp. 2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. mkatou@shinshu-u.ac.jp. 3. Department of Laboratory Medicine, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, Japan. mkatou@shinshu-u.ac.jp. 4. Department of Clinical Laboratory Sciences, School of Health Sciences, Shinshu University, Matsumoto, Japan. 5. Department of Laboratory Medicine, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, Japan. 6. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. 7. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Abstract
BACKGROUND: Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), a component of the Wnt receptor complex, is thought to lineage label gastric and intestinal stem cells. LGR5 expression is increased in colorectal carcinoma (CRC) compared to normal tissue. Colitis associated colorectal adenocarcinoma (CAC) often shows distinct morphologic and molecular phenotypes compared to sporadic cases. However, the expression profile of LGR5, and by extension the potential role of an intestinal stem cell phenotype, has not been well described in a series of human CAC. METHOD: RNA in situ hybridization (ISH) for LGR5 expression on 30 CACs (12 cases with conventional morphology and 18 cases with non-conventional type morphology) from 29 inflammatory bowel disease (IBD) patients was performed and compared the expression profile to a control group of 10 sporadic CRCs. Immunohistochemistry for beta-catenin and SATB2 was performed on the 30 CACs. RESULT: LGR5 was positive in 30% (9/30) of CAC cases and 90% (9/10) of sporadic CRCs (p = 0.002). A large majority (89%) of LGR5 positive CACs were of the conventional histologic type, and conventional type CAC showed a significantly higher LGR5 score (median 3.0; interquartile range 1.75-3.25) than non-conventional type CAC (median 1.5; interquartile range 1.00-2.00) (p = 0.034). CAC with conventional morphology did have a lower level of LGR5 expression than sporadic CRC. Sporadic CRCs showed a significantly higher LGR5 level score than non-conventional type CACs (p < 0.001). Nuclear translocation of beta-catenin was strongly associated with LGR5 expression (p = 0.003), however no significant association was identified between SATB2 expression and LGR5 expression status in CACs. CONCLUSION: These findings suggest that the wider spectrum of tumor morphology in CAC may be associated with absence of a LGR5-expressing intestinal stem cell phenotype.
BACKGROUND:Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), a component of the Wnt receptor complex, is thought to lineage label gastric and intestinal stem cells. LGR5 expression is increased in colorectal carcinoma (CRC) compared to normal tissue. Colitis associated colorectal adenocarcinoma (CAC) often shows distinct morphologic and molecular phenotypes compared to sporadic cases. However, the expression profile of LGR5, and by extension the potential role of an intestinal stem cell phenotype, has not been well described in a series of human CAC. METHOD: RNA in situ hybridization (ISH) for LGR5 expression on 30 CACs (12 cases with conventional morphology and 18 cases with non-conventional type morphology) from 29 inflammatory bowel disease (IBD) patients was performed and compared the expression profile to a control group of 10 sporadic CRCs. Immunohistochemistry for beta-catenin and SATB2 was performed on the 30 CACs. RESULT: LGR5 was positive in 30% (9/30) of CAC cases and 90% (9/10) of sporadic CRCs (p = 0.002). A large majority (89%) of LGR5 positive CACs were of the conventional histologic type, and conventional type CAC showed a significantly higher LGR5 score (median 3.0; interquartile range 1.75-3.25) than non-conventional type CAC (median 1.5; interquartile range 1.00-2.00) (p = 0.034). CAC with conventional morphology did have a lower level of LGR5 expression than sporadic CRC. Sporadic CRCs showed a significantly higher LGR5 level score than non-conventional type CACs (p < 0.001). Nuclear translocation of beta-catenin was strongly associated with LGR5 expression (p = 0.003), however no significant association was identified between SATB2 expression and LGR5 expression status in CACs. CONCLUSION: These findings suggest that the wider spectrum of tumor morphology in CAC may be associated with absence of a LGR5-expressing intestinal stem cell phenotype.
Authors: Ola Olén; Rune Erichsen; Michael C Sachs; Lars Pedersen; Jonas Halfvarson; Johan Askling; Anders Ekbom; Henrik Toft Sørensen; Jonas F Ludvigsson Journal: Lancet Date: 2020-01-11 Impact factor: 79.321
Authors: Mai Iwaya; Hiroyoshi Ota; Yoko Tateishi; Tomoyuki Nakajima; Robert Riddell; James R Conner Journal: Mod Pathol Date: 2019-02-01 Impact factor: 7.842
Authors: Bo Gun Jang; Hye Sung Kim; Weon Young Chang; Jeong Mo Bae; Woo Ho Kim; Gyeong Hoon Kang Journal: Am J Pathol Date: 2018-07-21 Impact factor: 4.307
Authors: Johan H van Es; Toshiro Sato; Marc van de Wetering; Anna Lyubimova; Annie Ng Yee Nee; Alex Gregorieff; Nobuo Sasaki; Laura Zeinstra; Maaike van den Born; Jeroen Korving; Anton C M Martens; Nick Barker; Alexander van Oudenaarden; Hans Clevers Journal: Nat Cell Biol Date: 2012-09-23 Impact factor: 28.824
Authors: Ann-Marie Baker; Trevor A Graham; George Elia; Nicholas A Wright; Manuel Rodriguez-Justo Journal: Sci Rep Date: 2015-03-02 Impact factor: 4.379